Stevanato Group S.p.A. (STVN) Revenue & Revenue Breakdown
Stevanato Group S.p.A. Revenue Highlights
Latest Revenue (Y)
$1.06B
Latest Revenue (Q)
$237.38M
Main Geography (Y)
Europe Middle East And Africa
Stevanato Group S.p.A. Revenue by Period
Stevanato Group S.p.A. Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $1.06B | 8.08% |
2022-12-31 | $983.70M | 16.57% |
2021-12-31 | $843.90M | 27.47% |
2020-12-31 | $662.04M | 23.39% |
2019-12-31 | $536.54M | - |
Stevanato Group S.p.A. Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | $237.38M | -24.02% |
2023-12-31 | $312.41M | 15.11% |
2023-09-30 | $271.40M | 6.31% |
2023-06-30 | $255.30M | 7.27% |
2023-03-31 | $237.99M | -18.52% |
2022-12-31 | $292.10M | 19.10% |
2022-09-30 | $245.26M | 4.70% |
2022-06-30 | $234.25M | 10.46% |
2022-03-31 | $212.07M | -8.82% |
2021-12-31 | $232.60M | 8.42% |
2021-09-30 | $214.53M | 5.18% |
2021-06-30 | $203.96M | 5.76% |
2021-03-31 | $192.85M | -6.72% |
2020-12-31 | $206.74M | 31.63% |
2020-09-30 | $157.06M | -2.94% |
2020-06-30 | $161.81M | 18.60% |
2020-03-31 | $136.43M | - |
Stevanato Group S.p.A. Revenue Breakdown
Stevanato Group S.p.A. Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 23 | Dec 22 |
---|---|---|
South America | $30.87M | $40.00M |
Asia Pacific | $102.90M | $117.75M |
Europe Middle East And Africa | $634.05M | $705.95M |
North America | $317.54M | $294.71M |
Stevanato Group S.p.A. Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ALC | Alcon | $10.09B | $2.46B |
RMD | ResMed | $4.69B | $1.20B |
XRAY | DENTSPLY SIRONA | $3.96B | $984.00M |
COO | Cooper Companies | $3.59B | $1.00B |
ATR | AptarGroup | $3.49B | $910.06M |
TFX | Teleflex | $2.97B | $749.69M |
WST | West Pharmaceutical Services | $2.95B | $702.00M |
NVST | Envista | $2.57B | $623.60M |
ICUI | ICU Medical | $2.26B | $596.46M |
HAE | Haemonetics | $1.31B | $336.17M |
MMSI | Merit Medical Systems | $1.26B | $338.00M |
STVN | Stevanato Group S.p.A. | $1.06B | $237.38M |
ATRC | AtriCure | $399.25M | $116.27M |
ANGO | AngioDynamics | $303.91M | $75.18M |
AKYA | Akoya Biosciences | $96.63M | $23.16M |
STVN Revenue FAQ
What is Stevanato Group S.p.A.’s yearly revenue?
Stevanato Group S.p.A.'s yearly revenue for 2023 was $1.06B, representing an increase of 8.08% compared to 2022. The company's yearly revenue for 2022 was $983.7M, representing an increase of 16.57% compared to 2021. STVN's yearly revenue for 2021 was $843.9M, representing an increase of 27.47% compared to 2020.
What is Stevanato Group S.p.A.’s quarterly revenue?
Stevanato Group S.p.A.'s quarterly revenue for Q1 2024 was $237.38M, a -24.02% decrease from the previous quarter (Q4 2023), and a -0.26% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $312.41M, a 15.11% increase from the previous quarter (Q3 2023), and a 6.95% increase year-over-year (Q4 2022). STVN's quarterly revenue for Q3 2023 was $271.4M, a 6.31% increase from the previous quarter (Q2 2023), and a 10.66% increase year-over-year (Q3 2022).
What is Stevanato Group S.p.A.’s revenue growth rate?
Stevanato Group S.p.A.'s revenue growth rate for the last 3 years (2021-2023) was 25.98%, and for the last 5 years (2019-2023) was 98.15%.